Are SGLT2 inhibitors effective against ‘all’ heart failure with preserved ejection fraction?-Reference-Cited by-同舟云学术

Are SGLT2 inhibitors effective against ‘all’ heart failure with preserved ejection fraction?

Published:2022-01-28 Issue:3 Volume:8 Page:E10-E10
ISSN:2055-6837
Container-title:European Heart Journal - Cardiovascular Pharmacotherapy
language:en
Short-container-title:

Author:

Hasegawa Koji¹^ORCID,Lewis Basil S²^ORCID

Affiliation:

1. Division of Translational Research, National Hospital Organization Kyoto Medical Center , 1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto 612-8555, Japan

2. Ruth and Bruce Rappaport School of Medicine, Technion—Israel Institute of Technology , Israel

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Link

https://academic.oup.com/ehjcvp/advance-article-pdf/8/3/E10/43555176/pvac004.pdf

Reference3 articles.

1. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure;McDonagh;Eur Heart J,2021

2. Effect of empagliflozin on worsening heart failure events in patients with heart failure and preserved ejection fraction:;Packer;Circulation,2021

3. Heart failure and a preserved ejection fraction: a side-by-side examination of the PARAGON-HF and EMPEROR-Preserved trials;Packer;Circulation,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The search for the holy grail: the balance between the risk of thrombosis and bleeding in patients;European Heart Journal - Cardiovascular Pharmacotherapy;2024-08

2. SGLT2 inhibitors in acute myocardial infarction: what can we learn from the DAPA-MI trial? More news from American Heart Association Scientific Meeting;European Heart Journal - Cardiovascular Pharmacotherapy;2023-12-07

3. The search for the perfect antiplatelet treatment continues;European Heart Journal - Cardiovascular Pharmacotherapy;2023-12

4. Atrial fibrillation has gone from a boring disease to a very hot condition. Why is that?;European Heart Journal - Cardiovascular Pharmacotherapy;2023-07-24

5. When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention;European Cardiology Review;2023-06-07